CorMedix Inc. (CRMD)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
A
Pipeline Grade

Financial Position (from SEC Filings)

$179.1M
Cash & Equivalents
$42.4M
Quarterly Burn Rate
$664M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (1 Assets)

DrugPhaseIndications
HEPARIN SODIUM, TAUROLIDINE
DEFENCATH 		APPROVED Acute Kidney Injury, Catheter-related Bloodstream Infection, Catheter-Related Infections, Central Line Associated Blood Stream Infections (CLABSI), Contrast-Induced Acute Kidney Injury, Kidney Failure, Chronic

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CRMD.

SEC EDGAR Filings

All SEC filings for CorMedix Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.